Key Financial Results (₹ in lacs)

Income Statement Performance

  • Revenue from Operations: ₹8,355 lacs (Q1 FY27) vs ₹5,588 lacs (Q1 FY26) - 49.5% YoY increase
  • Other Income: ₹315 lacs (Q1 FY27) vs ₹188 lacs (Q1 FY26)
  • Total Income: ₹8,669 lacs (Q1 FY27) vs ₹5,777 lacs (Q1 FY26) - 50.1% YoY increase

Expense Breakdown

  • Cost of Materials Consumed: ₹2,899 lacs (Q1 FY27) vs ₹1,086 lacs (Q1 FY26)
  • Employee Benefits Expense: ₹966 lacs (Q1 FY27) vs ₹984 lacs (Q1 FY26)
  • Finance Costs: ₹136 lacs (Q1 FY27) vs ₹4 lacs (Q1 FY26)
  • Depreciation and Amortization: ₹842 lacs (Q1 FY27) vs ₹406 lacs (Q1 FY26)
  • Other Expenses: ₹2,203 lacs (Q1 FY27) vs ₹1,835 lacs (Q1 FY26)
  • Total Expenses: ₹6,768 lacs (Q1 FY27) vs ₹4,214 lacs (Q1 FY26)

Profitability Metrics

  • Profit Before Tax: ₹1,902 lacs (Q1 FY27) vs ₹1,563 lacs (Q1 FY26) - 21.7% YoY increase
  • Tax Expense: ₹391 lacs total (₹249 lacs Current Tax + ₹142 lacs Deferred Tax)
  • Profit After Tax: ₹1,510 lacs (Q1 FY27) vs ₹1,203 lacs (Q1 FY26) - 25.5% YoY increase
  • Total Comprehensive Income: ₹1,512 lacs (Q1 FY27) vs ₹1,193 lacs (Q1 FY26)

Capital Structure and Per Share Data

  • Paid-up Equity Share Capital: ₹1,233 lacs (Face Value ₹5 per share) - unchanged from previous quarter
  • Earnings Per Share (Basic & Diluted): ₹6.13 (Q1 FY27) vs ₹4.88 (Q1 FY26)
  • Other Equity excluding Revaluation Reserves: ₹38,363 lacs (as of 31st March 2026)

Comparative Period Data

Previous quarter (Q4 FY26) comparison:

  • Revenue from Operations: ₹8,355 lacs (Q1 FY27) vs ₹5,514 lacs (Q4 FY26) - 51.5% QoQ increase
  • Profit After Tax: ₹1,510 lacs (Q1 FY27) vs ₹1,251 lacs (Q4 FY26) - 20.7% QoQ increase
  • EPS: ₹6.13 (Q1 FY27) vs ₹5.07 (Q4 FY26)

Board Meeting Details

  • Meeting Date: 30th July 2026
  • Commencement Time: 3:30 p.m.
  • Conclusion Time: 4:05 p.m. (35-minute duration)
  • Primary Agenda: Approval of Unaudited Financial Results for quarter ended 30th June 2026

Auditor Review and Compliance

  • Auditor: CNK & Associates LLP (Firm Registration No: 101961W/W-100036)
  • Review Standard: Standard on Review Engagements (SRE) 2410
  • Conclusion: No material misstatement identified in the unaudited financial results
  • Compliance: Prepared in accordance with Ind AS 34 and SEBI Listing Regulations
  • Historical Reference: Q1 FY25 results were reviewed by predecessor auditor with unmodified opinion

Business Segment Information

  • The Company operates in a single reportable segment: Speciality Chemicals

Accounting Notes

  • Previous quarter EPS figures have been restated to account for sub-division of shares and bonus share allotment in line with IND AS 33 requirements
  • Q4 FY26 figures represent balancing figures between audited annual results and unaudited YTD figures up to Q3 FY26
  • Previous periods' figures have been regrouped/rearranged for comparability